Turnbridge Capital
Turnbridge Capital, LLC is a private equity firm established in 2008 and headquartered in Dallas, Texas, with an additional office in Houston. The firm specializes in management buyouts, corporate spinouts, leveraged build-ups, and shareholder recapitalizations, primarily focusing on middle-market and emerging growth companies. Turnbridge Capital targets investments in the energy and infrastructure sectors, including energy equipment and services, industrial manufacturing, and transportation and distribution. The firm typically invests between $10 million and $100 million in companies with enterprise values ranging from $50 million to $250 million, and revenues between $25 million and $250 million. It aims for majority ownership and generally holds investments for three to seven years, depending on the circumstances of each portfolio company. Turnbridge Capital employs its personal capital for these investments and does not pursue turnaround opportunities.
Gradiant Energy Services, Inc. is an oilfield services company specializing in water treatment solutions for the oil and gas industry, particularly in the Permian and Marcellus shale regions. Founded in 2012 and headquartered in Denver, Colorado, with a regional office in Midland, Texas, the company offers various services, including bacteria treatment, re-usable clean brine, evaporative disposal, and freshwater/desalination. Gradiant Energy Services focuses on helping exploration and production operators manage the treatment, reuse, and recycling of flowback and produced water. The company aims to provide safe, reliable, and cost-effective solutions that address the growing challenges associated with water usage and wastewater management in oil extraction processes.
Cimarron Energy specializes in the design and manufacturing of equipment for oil and gas production and processing. With over three decades of experience, the company focuses on providing high-quality products that facilitate the efficient separation of oil, natural gas, and water from hydrocarbon streams. Their equipment is essential for exploration and production companies across the United States, helping to ensure safe and environmentally responsible treatment and disposal of by-products. Cimarron Energy is recognized for its innovative engineering solutions and exceptional customer service, maintaining strong communication with clients to adapt to their specific project needs.
Morphotek is a prominent life science company focused on developing innovative biological products for the treatment of cancer, inflammatory conditions, and infectious diseases. Established in 2000, Morphotek specializes in the discovery and development of monoclonal antibodies (mABs) and conducts research and clinical development programs for its own drug candidates. The company targets various ailments, including ovarian and pancreatic cancers, rheumatoid arthritis, and asthma. The foundation of Morphotek's technology lies in morphogenics, co-invented by Dr. Nicholas Nicolaides during his post-graduate studies at Johns Hopkins Medical School, alongside co-founders Dr. Philip Sass and Dr. Luigi Grasso. This proprietary technology has significantly advanced Morphotek's capabilities in creating novel pharmaceutical products and therapeutic targets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.